Аннотация:South Africa's drug-susceptible tuberculosis (TB) ‘tap’ may have been turned down a few notches by the sustained HIV/AIDS testing and antiretroviral therapy campaign, but a growing number of dying, drug-resistant TB sufferers are desperately awaiting the approval of drugs known to be effective.
